Christopher Ho

1.4k citations
8 papers · 1.2k · 1 hit paper · h-index 8

Impact in

Papers in

Christopher Ho

8 papers receiving 1.2k citations

Christopher Ho's Hit Papers

Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARγ–Modulating Activity 2004 · 928 citations
9280+7+14Years since publication250500750

Peers

Christopher Ho
Comparison fields: 5 of 83
  • Cardiology and Cardiovascular Medicine 380
  • Endocrinology, Diabetes and Metabolism 289
  • Biochemistry 121
  • Physiology 220
  • Pharmacology 130
Replace Nianning Qi with:
Nianning Qi United States
Yoshiko Tokutomi Japan
María Antonia Fortuño Spain
De‐Zai Dai China
Ming-Sheng Zhou China
Annemarieke E. Loot Germany
Arnold D. Essenburg United States
Kazuhisa Takeuchi Japan
Yue Du China
Yi‐Fei Dong Japan
Christopher Ho relative to Nianning Qi United States Nianning Qi's profile →
Citations per field
00.5×1.5×
Nianning Qi · 1×
Citations per year

Countries citing papers authored by Christopher Ho

Since Specialization
Citations

This map shows the geographic impact of Christopher Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Ho more than expected).

Fields of papers citing papers by Christopher Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Ho. The network helps show where Christopher Ho may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher Ho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher Ho Line = papers co-authored together Christopher Ho links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1
Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARγ–Modulating Activity
Hit paper breakdown →
2004928
2 200764
3 201151
4 200447
5 200642
6 200934
7 200831
8 20108

About Christopher Ho

Christopher Ho is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Biochemistry, Clinical Biochemistry and Genetics, having authored 8 papers that have together received 1.2k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (4 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Receptor Mechanisms and Signaling (2 papers), Renin-Angiotensin System Studies (2 papers), Heart Failure Treatment and Management (1 paper), NF-κB Signaling Pathways (1 paper), Biochemical Acid Research Studies (1 paper) and Genetic Syndromes and Imprinting (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (380 citations), Endocrinology, Diabetes and Metabolism (289 citations), Biochemistry (121 citations), Physiology (220 citations) and Pharmacology (130 citations). Christopher Ho has collaborated with scholars based in United States, Japan and Czechia. Frequent co-authors include Theodore W. Kurtz, Stephen C. Benson, Mitchell A. Avery, Harrihar A. Pershadsingh, Amar G. Chittiboyina, Prashant Desai, Michal Pravenec, Nianning Qi, Jiaming Wang and Jiaming Wang. Their work appears in journals such as Journal of Hypertension, Hypertension, Journal of Medicinal Chemistry, Journal of Investigative Dermatology and Genome Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact